Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same author

Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.

Therapeutic advances in neurological disorders·2026
Same author

Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoring.

Neurological research and practice·2026
Same author

Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS.

Journal of neuroinflammation·2026
Same author

Recanalization therapy in stroke patients with malignancies: in-hospital outcomes by cancer subtype in a nationwide administrative data analysis.

Journal of neurology·2026
Same author

A CSF disease-associated macrophage signature defines progressive multiple sclerosis.

Journal of neuroinflammation·2026

Related Experiment Video

Updated: Nov 9, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K

Classification of neurological diseases using multi-dimensional CSF analysis.

Catharina C Gross1, Andreas Schulte-Mecklenbeck1, Lohith Madireddy2

  • 1Department of Neurology with Institute of Translational Neurology, University and University Hospital Münster, 48149 Münster, Germany.

Brain : a Journal of Neurology
|April 13, 2021
PubMed
Summary
This summary is machine-generated.

Integrated analysis of blood and cerebrospinal fluid (CSF) parameters aids in diagnosing similar neurological diseases. This approach improves differential diagnosis and supports early treatment decisions for CNS conditions.

Keywords:
CNS autoimmunityCSFdifferential diagnosisimmune profilemultiple sclerosis

More Related Videos

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.0K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.8K

Related Experiment Videos

Last Updated: Nov 9, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.0K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.8K

Area of Science:

  • Neuroscience
  • Immunology
  • Data Science

Background:

  • Cerebrospinal fluid (CSF) analysis is crucial for diagnosing central nervous system (CNS) diseases, primarily distinguishing between infectious, autoimmune inflammatory, and degenerative disorders.
  • Current diagnostic methods often lack the granularity to differentiate between clinically similar neurological conditions.
  • A need exists for advanced analytical approaches to refine differential diagnosis in neurology.

Purpose of the Study:

  • To determine if multi-dimensional cellular characterization of blood and CSF can aid in diagnosing clinically similar neurological diseases.
  • To identify biomarkers that differentiate various neurological conditions, including subtypes of autoimmune neuroinflammatory diseases.
  • To assess the utility of integrated biomarker analysis in clinical decision-making.

Main Methods:

  • Retrospective cross-sectional study of 546 patients with autoimmune neuroinflammatory, degenerative, or vascular CNS conditions.
  • Application of feature selection, dimensionality reduction, and machine learning algorithms to blood and CSF data.
  • Validation of findings in an independent cohort of 231 patients.

Main Results:

  • Identification of "pan-disease" parameters altered across autoimmune neuroinflammatory CNS diseases, differentiating them from other neurological conditions.
  • Development of "inter-autoimmunity classifiers" to subdifferentiate variants of CNS-directed autoimmunity.
  • Demonstration that integrated analysis of blood and CSF parameters, combined into composite scores, improves patient classification and reflects disease evolution.

Conclusions:

  • Integrated analysis of blood and CSF parameters significantly enhances the differential diagnosis of neurological diseases.
  • This multi-dimensional approach facilitates earlier and more precise treatment decisions for patients with CNS disorders.
  • The study highlights the potential of advanced data analysis techniques in clinical neurology.